The Latest Breaking News from Jazz

Jazz Pharmaceuticals (NASDAQ:JAZZ) has observed the following analyst ratings within the last quarter:

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) has acquired development and commercialization rights in the U.S., Europe, and other territories for Sumitomo Pharma's investigational DSP-0187. DSP-0187 is a potent, highly selective oral orexin-2 receptor agonist with potential application for treating narcolepsy, idiopathic hypersomnia, and other sleep disorders.  Jazz has designated this molecule JZP441. Sumitomo Pharma initiated a Phase…

He's getting used to this.

Eight teams are left. Which contender has the best chance to win it all?

FORT WORTH, Texas — Donovan Mitchell versus Luka Doncic should have been a great series, but it wasn't that close.

It looks like the Lakers have zeroed in on one of their top coaching cadidates.

Will the Jaguars’ gamble pay off?

The Utah Jazz postseason ended in sorry fashion yet again. They blew a large series lead in their previous two playoff eliminations and this time got shut out by a Mavericks team without Luka Doncic for half the games. It appears teams have figured ...

The vultures are circling Utah after a third consecutive playoff defeat before the conference finals. Does the team really have to blow it all up?